These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
514 related items for PubMed ID: 11746775
1. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation. Soos JM, Krieger JI, Stüve O, King CL, Patarroyo JC, Aldape K, Wosik K, Slavin AJ, Nelson PA, Antel JP, Zamvil SS. Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775 [Abstract] [Full Text] [Related]
4. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma. Piskurich JF, Gilbert CA, Ashley BD, Zhao M, Chen H, Wu J, Bolick SC, Wright KL. Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283 [Abstract] [Full Text] [Related]
8. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene. Rohn W, Tang LP, Dong Y, Benveniste EN. J Immunol; 1999 Jan 15; 162(2):886-96. PubMed ID: 9916712 [Abstract] [Full Text] [Related]
11. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines. Goodwin BL, Xi H, Tejiram R, Eason DD, Ghosh N, Wright KL, Nagarajan U, Boss JM, Blanck G. Cell Growth Differ; 2001 Jun 15; 12(6):327-35. PubMed ID: 11432807 [Abstract] [Full Text] [Related]
12. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma. Zhao M, Flynt FL, Hong M, Chen H, Gilbert CA, Briley NT, Bolick SC, Wright KL, Piskurich JF. Mol Immunol; 2007 Apr 15; 44(11):2923-32. PubMed ID: 17300840 [Abstract] [Full Text] [Related]
13. Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis. Waldburger JM, Palmer G, Seemayer C, Lamacchia C, Finckh A, Christofilopoulos P, Baeten D, Reith W, Gabay C. Arthritis Rheum; 2011 Nov 15; 63(11):3354-63. PubMed ID: 21739421 [Abstract] [Full Text] [Related]
15. Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator. Pai RK, Askew D, Boom WH, Harding CV. J Immunol; 2002 Aug 01; 169(3):1326-33. PubMed ID: 12133955 [Abstract] [Full Text] [Related]
18. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation. Meissner M, Whiteside TL, van Kuik-Romein P, Valesky EM, van den Elsen PJ, Kaufmann R, Seliger B. Br J Dermatol; 2008 May 01; 158(5):930-40. PubMed ID: 18284388 [Abstract] [Full Text] [Related]
19. Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. Waldburger JM, Suter T, Fontana A, Acha-Orbea H, Reith W. J Exp Med; 2001 Aug 20; 194(4):393-406. PubMed ID: 11514597 [Abstract] [Full Text] [Related]